Losartan attenuates phospholipase C isozyme gene expression in hypertrophied hearts due to volume overload

Journal of Cellular and Molecular Medicine

Volumn 10, Issue 2, 2006, Pages 470-479

  Dent, Melissa R ^a   Aroutiounova, Nina ^a   Dhalla, N S ^a   Tappia, P S ^a,b,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Angiotensin II type 1 receptor antagonist; Cardiac hypertrophy; Gene expression; Phospholipase C; Volume overload

Indexed keywords

ANIMALIA; RATTUS;

ANGIOTENSIN RECEPTOR ANTAGONIST; ISOENZYME; LOSARTAN; MESSENGER RNA; PHOSPHOLIPASE C;

ANIMAL; ARTICLE; CARDIOMEGALY; COMPARATIVE STUDY; GENE EXPRESSION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CARDIOMEGALY; GENE EXPRESSION; ISOENZYMES; LOSARTAN; PHOSPHOLIPASE C; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 33747195339     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2006.tb00412.x     Document Type: Article

References (40)

1. D'Santos CS, Clarke JH, Divecha N. Phospholipid signaling in the nucleus. Biochim Biophys Acta 1998; 1436: 201-32.
2. James SR, Downes CP. Structural and mechanistic features of phospholipases C: effectors of inositol phospholipid-mediated signal transduction. Cell Signal 1997; 9: 329-36.
3. Katan M. Families of phosphoinositide-specific phospholipase C: structure and function. Biochim Biophys Acta 1998; 1436: 5-17.
4. Rhee SG. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem. 2001; 70: 281-312.
5. Gilbert JC, Shirayama T, Pappano AJ. Inositol trisphosphate promotes Na-Ca exchange current by releasing calcium from sarcoplasmic reticulum in cardiac myocytes. Circ Res. 1991; 69: 1632-9.
6. 3 binding site in rat heart sarcoplasmic reticulum. J Mol Cell Cardiol. 1994; 26: 341-349.
7. Kijimi Y, Fleischer S. Two types of inositol trisphosphate binding in cardiac microsomes. Biochem Biophys Res Commun. 1992; 189: 728-35.
8. Kijimi Y, Saito A, Jetton TL, Magnuson MA, Fleischer S. Different intracellular localization of inositol 1,4,5-trisphosphate and ryanodine receptors in cardiomyocytes. J Biol Chem. 1993; 268: 3499-506.
9. Puceat M, Vassort G. Signaling by protein kinase C isoforms in the heart. Mol Cell Biochem. 1996; 157: 65-72.
10. 2+ uptake mechanism in cardiac junctional sarcoplasmic reticulum. Biochem Biophys Res Commun. 1994; 204: 69-75.
11. 1 and tissue reninangiotensin system in the progression of cardiac hypertrophy [in Japanese]. Hokkaido Igaku Zasshi 1993; 68: 18-28.
12. Kawaguchi H, Sano H, Iizuka K, Okada H, Kudo T, Kageyama K, Muramoto, Murakami T, Okamoto H, Mochizuki N. Phosphatidylinositol metabolism in hypertrophic rat heart. Circ Res. 1993; 72: 966-72.
13. Shoki M, Kawaguchi H, Okamoto H, Sano H, Sawa H, Kudo T, Hirao N, Sakata Y, Yasuda H. Phosphatidylinositol and inositolphosphatide metabolism in hypertrophied rat heart. Jpn Circ J. 1992; 56: 142-7.
14. Lamers JM, Eskildsen-Helmond YE, Resink AM, de Jonge HW, Bezstarosti K, Sharma HS, van Heugten HA. Endothelin-1-induced phospholipase C β- and D and protein kinase C isoenzyme signaling leading to hypertrophy in rat cardiomyocytes. J Cardiovasc Pharmacol. 1995; 26: S100-3.
15. Schnabel P, Mies F, Nohr T, Geisler M, Bohm M. Differential regulation of phospholipase C-β isozymes in cardiomyocyte hypertrophy. Biochem Biophys Res Commun. 2000; 275: 1-6.
16. Singal T, Dhalla NS, Tappia PS. Phospholipase C may be involved in norepinephrine-induced cardiac hypertrophy. Biochem Biophys Res Commun. 2004; 320: 1015-9.
17. Dent MR, Dhalla NS, Tappia PS. Phospholipase C gene expression, protein content, and activities in cardiac hypertrophy and heart failure due to volume overload. Am J Physiol Heart Circ Physiol. 2004; 287: H719-27.
18. Sentex E, Wang X, Liu X, Lukas A, Dhalla NS. Expression of protein kinase C isoforms in cardiac hypertrophy and heart failure due to volume overload. Can J Physiol Pharmacol. 2006; 84: 227-38.
19. Sethi R, Saini HK, Wang X, Elimban V, Babick A, Dhalla NS. Differential changes in β-adrenoceptor signal transduction in left and right ventricles of infarcted rats. Can J Physiol Pharmacol. 2006; in press.
20. Wang X, Sentex E, Saini HK, Chapman D, Dhalla NS. Upregulation of β-adrenergic receptors in heart failure due to volume overload. Am J Physiol Heart Circ Physiol. 2005; 289: H151-9.
21. Wang X, Sentex E, Chapman D, Dhalla NS. Alterations of adenylyl cyclase and G proteins in aortocaval shunt-induced heart failure. Am J Physiol Heart Circ Physiol. 2004; 287: H118-25.
22. Wang X, Ren B, Liu SY, Sentex E, Tappia PS, Dhalla NS. Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J Appl Physiol. 2003; 94: 752-63.
23. Kannel WB. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur Heart J. 1987; 8: 23-6.
24. Cantor EJ, Babick AP, Vasanji Z, Dhalla NS, Netticadan T. A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload. J Mol Cell Cardiol. 2005; 38: 777-86.
25. Rudolph W. Pathophysiologic and diagnostic aspects of heart failure. Herz 1990; 15: 147-57.
26. Sabri A, Steinberg SF. Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure. Mol Cell Biochem. 2003; 251: 97-101.
27. Yamakawa H, Imamura T, Matsuo T, Onitsuka H, Tsumori Y, Kato J, Kitamura K, Koiwaya Y, Eto T. Diastolic wall stress and ANG II in cardiac hypertrophy and gene expression induced by volume overload. Am J Physiol. 2000; 279: H2939-46.
28. 1 receptor antagonist on volume overload-induced cardiac gene expression in rats. Hypertens Res. 1997; 20: 133-42.
29. 1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin. Eur J Pharmacol 1995; 280: 11-7.
30. Ruzicka M, Yuan B, Leenen FH. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. Circulation 1994; 90: 484-91.
31. Ishiye M, Umemura K, Uematsu T, Nakashima M. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload. Biol Pharm Bull. 1995; 18: 700-4.
32. Ruzicka M, Yuan B, Harmsen E, Leenen FH. The reninangiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Circulation 1993; 87: 921-30.
33. Wang X, Dhalla NS. Modification of β-adrenoceptor signal transduction pathway by genetic manipulation and heart failure. Mol Cell Biochem. 2000; 214: 131-55.
34. 2+ exchanger expression in heart failure by blockade of renin-angiotensin system. Am J Physiol. 2005; 288: H2637-46.
35. Modesti PA, Vanni S, Bertolozzi I, Cecioni I, Polidori G, Paniccia R, Bandinelli B, Perna A, Liguori P, Boddi M, Galanti G, Serneri GG. Early sequence of cardiac adaptations and growth factor formation in pressure-and volume-overload hypertrophy. Am J Physiol Heart Circ Physiol. 2000; 279: H976-85.
36. Volterranni M, Giustina A, Manelli F, Cicoira MA, Lorusso R, Giordano A. Role of growth hormone in chronic heart failure: therapeutic implications. Ital Heart J. 2000; 1: 732-8.
37. Eskildren-Helmond YEG, Bezstarosti K, Dekkers DHW, van Heugten HAA, Lamers JMJ. Cross-talk between receptor-mediated phospholipase C-β and D via protein kinase C as intracellular signal possibly leading to hypertrophy in serum-free cultured cardiomyocytes. J Mol Cell Cardiol. 1997: 29: 2545-59.
38. Goutsouliak V, Rabkin SW. Angiotensin II-induced inositol phosphate generation is mediated through tyrosine kinase pathways in cardiomyocytes. Cell Signal 1997; 9: 505-12.
39. Van Bilsen M. Signal transduction revisited: recent developments in angiotensin II signaling in the cardiovascular system. Cardiovasc Res. 1997; 36: 310-22.
40. Singal T, Dhalla NS, Tappia PS. Phospholipase C mRNA expression is regulated by a protein kinase C and ERK 1/2-dependent pathway in adult rat cardiomyocytes (Abstract). J Mol Cell Cardiol. 2005; 38: A112.